Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
Simvastatin regulates oligodendroglial process dynamics and survival.
Deafness in Patients with Multiple Sclerosis.
Combined oral contraceptives: health benefits beyond contraception.
Merck KGaA to try again to get approval for MS pill cladribine
Anesthetic management of a parturient with neuromyelitis optica.
ATP increases the migration of microglia across the brain endothelial cell monolayer.
A case of recurrent optic neuritis associated with cerebral and spinal cord lesions and autoantibodies against myelin oligodendrocyte glycoprotein relapsed after fingolimod therapy.
Fulminant demyelinating diseases.
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Genetic characterization of gliomas arising in patients with multiple sclerosis.
Active intrathecal herpes simplex virus type 1 (HSV-1) and human herpesvirus-6 (HHV-6) infection at onset of multiple sclerosis.
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Orbital Doppler evaluation of blood flow velocities in optic neuritis.
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.
Review: the role of vitamin D in nervous system health and disease.
Relapsing-remitting multiple sclerosis and chronic idiopathic neutropenia: a challenging combination.
Neuroaxonal regeneration is more pronounced in early multiple sclerosis than in traumatic brain injury lesions.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients.
AB Science announces successful non futility test for masitinib in progressive forms of multiple sclerosis
The invisible gorilla strikes again: sustained inattentional blindness in expert observers.
Tumefactive demyelinating lesions during etanercept treatment requiring decompressive hemicraniectomy.

Pages